Francois Rochon Medpace Holdings, Inc. Transaction History

Giverny Capital Inc.

$2.63 Billion
Q2 2025

A detailed history of Francois Rochon (Giverny Capital Inc.) transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Giverny Capital Inc. holds 261,755 shares of MEDP stock, worth $139 Million. This represents 3.13% of its overall portfolio holdings.

Number of Shares

261,755

Previous 251,937 3.9%

Holding current value

$139 Million

Previous $76.8 Million 7.02%

% of portfolio

3.13%

Previous 3.09%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$277.23 - $315.28 $2.72 Million - $3.1 Million	9,818 Added 3.9%	261,755 $82.2 Million
Q1 2025 Aug 12, 2025	BUY	$304.69 - $360.97 $5.38 Million - $6.37 Million	17,650 Added 7.53%	251,937 $76.8 Million
Q1 2025 May 13, 2025	BUY	$304.69 - $360.97 $5.38 Million - $6.37 Million	17,650 Added 7.53%	251,937 $76.8 Million
Q4 2024 Aug 12, 2025	SELL	$308.93 - $363.58 $5.45 Million - $6.42 Million	-17,650 Reduced 7.01%	234,287 $77.8 Million
Q4 2024 Feb 13, 2025	BUY	$308.93 - $363.58 $2.23 Million - $2.62 Million	7,215 Added 3.18%	234,287 $77.8 Million
Q3 2024 Nov 13, 2024	BUY	$320.58 - $457.29 $12.5 Million - $17.8 Million	38,978 Added 20.72%	227,072 $75.7 Million
Q2 2024 Aug 14, 2024	BUY	$372.0 - $424.34 $1.06 Million - $1.21 Million	2,862 Added 1.55%	188,094 $77.5 Million
Q1 2024 May 13, 2024	BUY	$284.87 - $413.31 $7.85 Million - $11.4 Million	27,568 Added 17.49%	185,232 $74.9 Million
Q4 2023 Feb 09, 2024	BUY	$227.52 - $312.68 $35 Million - $48.1 Million	153,904 Added 4093.19%	157,664 $48.3 Million
Q3 2023 Jan 25, 2024	BUY	$233.98 - $281.67 $879,764 - $1.06 Million	3,760 New	3,760 $910,000

Others Institutions Holding MEDP

# of Institutions

649

Shares Held

26.9M

Call Options Held

54.2K

Put Options Held

108K

View Full List

About Medpace Holdings, Inc.

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $16.6B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

More about MEDP

Track Francois Rochon's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Giverny Capital Inc., based on Form 13F filings with the SEC.

News

Stay updated on Giverny Capital Inc. and Francois Rochon with notifications on news.

Account